---
figid: PMC4505489__zbc0291519330008
figlink: /pmc/articles/PMC4505489/figure/F8/
number: F8
caption: NAMPT inhibition leads to alterations of different metabolic pathways in
  cancer cells. NAMPT inhibition affects the glycolytic, pentose phosphate pathway,
  serine biosynthetic pathways, and the TCA cycle. The affected metabolites are highlighted
  in either red (increased) or green (decreased). The blockade of the glyceraldehyde-3-phosphate
  dehydrogenase (G3PDH) step is indicated (×). HK, hexokinase; PGI, phosphoglucose
  isomerase; PFK, phosphofructose kinase; TPI, triose-phosphate isomerase; PGK, phosphoglycerate
  kinase; PGM, phosphoglycerate mutase; PKM2, pyruvate kinase 2; LDH, lactate dehydrogenase;
  G6PDH, glucose-6-phosphate dehydrogenase; G6P, glucose 6-phosphate; 6PGLA, 6-phosphogluconolactonase;
  Gn6P, 6-phosphogluconate; Gn6PDH, 6-phosphogluconate dehydrogenase; NMN, nicotinamide
  mononucleotide adenine; NMNAT, nicotinamide mononucleotide adenine transferase;
  3PG, 3-phosphoglycerate; 3PGDH, 3-phosphoglycerate dehydrogenase; p-ser, phosphoserine;
  PSAT, phosphoserine aminotransferase; PSPH, phosphoserine phosphatase; SHMT, serine
  hydroxymethyltransferase; CS, citrate synthase; IDH, isocitrate dehydrogenase; α-KG,
  α-ketoglutarate; α-KGDH, α-ketoglutarate dehydrogenase; SDH, succinate dehydrogenase;
  FH, fumarate hydratase; MDH, malate dehydrogenase; PDH, pyruvate dehydrogenase;
  F6P, fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; BPG, 1,3-bisphosphoglycerate;
  2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; 6PGL, 6-phosphogluconolactone;
  E4P, erythrose 4-phosphate; xylulose5P, xylulose 5-phosphate; ribose5P, ribose 5-phosphate;
  ribulose5P, ribulose 5-phosphate; THF, tetrahydrofolate; MTHF, 5,10-methylenetetrahydrofolate;
  3PHP, 3-phosphohydroxypyruvate; NAM, nicotinamide.
pmcid: PMC4505489
papertitle: Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme
  Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer
  Cells.
reftext: Bo Tan, et al. J Biol Chem. 2015 Jun 19;290(25):15812-15824.
pmc_ranked_result_index: '10997'
pathway_score: 0.95297
filename: zbc0291519330008.jpg
figtitle: NAMPT inhibition leads to alterations of different metabolic pathways in
  cancer cells
year: '2015'
organisms: Homo sapiens
ndex: 0b1b54d8-deec-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4505489__zbc0291519330008.html
  '@type': Dataset
  description: NAMPT inhibition leads to alterations of different metabolic pathways
    in cancer cells. NAMPT inhibition affects the glycolytic, pentose phosphate pathway,
    serine biosynthetic pathways, and the TCA cycle. The affected metabolites are
    highlighted in either red (increased) or green (decreased). The blockade of the
    glyceraldehyde-3-phosphate dehydrogenase (G3PDH) step is indicated (×). HK, hexokinase;
    PGI, phosphoglucose isomerase; PFK, phosphofructose kinase; TPI, triose-phosphate
    isomerase; PGK, phosphoglycerate kinase; PGM, phosphoglycerate mutase; PKM2, pyruvate
    kinase 2; LDH, lactate dehydrogenase; G6PDH, glucose-6-phosphate dehydrogenase;
    G6P, glucose 6-phosphate; 6PGLA, 6-phosphogluconolactonase; Gn6P, 6-phosphogluconate;
    Gn6PDH, 6-phosphogluconate dehydrogenase; NMN, nicotinamide mononucleotide adenine;
    NMNAT, nicotinamide mononucleotide adenine transferase; 3PG, 3-phosphoglycerate;
    3PGDH, 3-phosphoglycerate dehydrogenase; p-ser, phosphoserine; PSAT, phosphoserine
    aminotransferase; PSPH, phosphoserine phosphatase; SHMT, serine hydroxymethyltransferase;
    CS, citrate synthase; IDH, isocitrate dehydrogenase; α-KG, α-ketoglutarate; α-KGDH,
    α-ketoglutarate dehydrogenase; SDH, succinate dehydrogenase; FH, fumarate hydratase;
    MDH, malate dehydrogenase; PDH, pyruvate dehydrogenase; F6P, fructose 6-phosphate;
    FBP, fructose 1,6-bisphosphate; BPG, 1,3-bisphosphoglycerate; 2PG, 2-phosphoglycerate;
    PEP, phosphoenolpyruvate; 6PGL, 6-phosphogluconolactone; E4P, erythrose 4-phosphate;
    xylulose5P, xylulose 5-phosphate; ribose5P, ribose 5-phosphate; ribulose5P, ribulose
    5-phosphate; THF, tetrahydrofolate; MTHF, 5,10-methylenetetrahydrofolate; 3PHP,
    3-phosphohydroxypyruvate; NAM, nicotinamide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FBP1
  - VCAN
  - PRKG1
  - USF2
  - WDTC1
  - PKM
  - PAEP
  - PGLS
  - SDHB
  - PDHX
  - LDHA
  - FH
  - PDHA2
  - IDH2
  - PDHA1
  - PSPH
  - LDHB
  - PDHB
  - NAMPT
  - DLAT
  - LDHC
  - DLD
  - NMNAT1
  - SHMT1
  - FAD
  - Glucose
  - Glyceraldehyde
  - Glycine
  - Isocitrate
  - Oxaloacetate
  - Pyruvate
  - Ser
  - Succinate
  - Glu
  - Lactate
genes:
- word: FBP
  symbol: FBP
  source: hgnc_prev_symbol
  hgnc_symbol: FBP1
  entrez: '2203'
- word: PGM
  symbol: PG-M
  source: hgnc_alias_symbol
  hgnc_symbol: VCAN
  entrez: '1462'
- word: PGK
  symbol: PGK
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: FIP
  symbol: FIP
  source: hgnc_alias_symbol
  hgnc_symbol: USF2
  entrez: '7392'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: 6PGL
  symbol: 6PGL
  source: hgnc_alias_symbol
  hgnc_symbol: PGLS
  entrez: '25796'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: FH
  symbol: FH
  source: hgnc_symbol
  hgnc_symbol: FH
  entrez: '2271'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: IDH2|IDH3
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: PSPH
  symbol: PSPH
  source: hgnc_symbol
  hgnc_symbol: PSPH
  entrez: '5723'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHB
  entrez: '3945'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: LDH
  symbol: LDH
  source: bioentities_symbol
  hgnc_symbol: LDHC
  entrez: '3948'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: NMNAT
  symbol: NMNAT
  source: hgnc_alias_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
- word: SHMT
  symbol: SHMT
  source: hgnc_alias_symbol
  hgnc_symbol: SHMT1
  entrez: '6470'
chemicals:
- word: FAD
  source: MESH
  identifier: D005182
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glyceraldehyde
  source: MESH
  identifier: D005985
- word: Glycine
  source: MESH
  identifier: D005998
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Oxaloacetate
  source: MESH
  identifier: D010071
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Ser
  source: MESH
  identifier: D012694
- word: Succinate
  source: MESH
  identifier: D013386
- word: Glu
  source: MESH
  identifier: D018698
- word: Lactate
  source: MESH
  identifier: D019344
diseases: []
figid_alias: PMC4505489__F8
redirect_from: /figures/PMC4505489__F8
figtype: Figure
---
